Literature DB >> 26106171

Stroke and patent foramen ovale: intervene or wait.

Arti Khistriya1, Rannie Nahas1, Muhammad Javaid Hameed Rahmani1.   

Abstract

A 33-year-old woman presented to the emergency department with an acute left partial anterior circulation ischaemic stroke. Thrombolysis was not administered due to a rapidly improving National Institutes of Health Stroke Scale (NIHSS) score and she was thereafter given appropriate treatment for secondary prevention. CT and MRI demonstrated a left basal ganglia infarct with haemorrhagic transformation. Initial investigations revealed no evidence of atrial fibrillation or large vessel disease. Further investigation with transthoracic, bubble contrast and transoesophageal echocardiogram all indicated the presence of a grade 1 tunnel-shaped patent foramen ovale (PFO) with some aneurysmal interatrial septum. No other cause for her stroke was found. There is no current evidence to support the routine use of percutaneous PFO closure in prevention of stroke or transient ischaemic attack. National guidelines advise transcatheter closure of PFO should only be considered for patients with recurrent cryptogenic stroke on optimal medical management. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26106171      PMCID: PMC4480098          DOI: 10.1136/bcr-2014-208866

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Prevalence of patent foramen ovale in patients with stroke.

Authors:  P Lechat; J L Mas; G Lascault; P Loron; M Theard; M Klimczac; G Drobinski; D Thomas; Y Grosgogeat
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

2.  Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors:  R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal:  Ann Neurol       Date:  1989-04       Impact factor: 10.422

3.  Patent foramen ovale in young stroke patients.

Authors:  M W Webster; A M Chancellor; H J Smith; D L Swift; D N Sharpe; N M Bass; G L Glasgow
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

4.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

5.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

6.  Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events.

Authors:  J A Dearani; B S Ugurlu; G K Danielson; R C Daly; C G McGregor; C J Mullany; F J Puga; T A Orszulak; B J Anderson; R D Brown; H V Schaff
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Surgical closure of patent foramen ovale in cryptogenic stroke patients.

Authors:  S Homma; M R Di Tullio; R L Sacco; R R Sciacca; C Smith; J P Mohr
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

8.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

9.  Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis.

Authors:  M A Orgera; P G O'Malley; A J Taylor
Journal:  South Med J       Date:  2001-07       Impact factor: 0.954

10.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors:  John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.